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ABSTRACT: A cytogenetic study of  two cases of carcinoma in situ of the testis (CIS) and their adjacent 
invasive tumors, one a nonseminomatous germ cell tumor (NS) and one a seminoma (SE), revealed sim- 
ilarities in chromosomal pattern between the CIS and the invasive lesion in the same patient. These 
findings present for the first time cytogenetic evidence that CIS of the testis and its adjacent germ cell 
tumor are clonally related, which suggests that the CIS is indeed the precursor lesion of  the invasive 
tumor. 
INTRODUCTION 
Testicular germ cell tumors (TGCTs) are thought o be de- 
rived from dysplastic germ cell precursors (gonocytes), 
which progress to carcinoma in situ (CIS) [1]. This as- 
sumption is supported by the frequent observation of CIS 
in the testicular parenchyma surrounding invasive cancer 
[2], as well as by the development of invasive TGCT in pa- 
tients where CIS had been diagnosed previously [3, 4]. 
Thus CIS is considered the precursor for all subtypes of 
TGCTs of adolescents and adults, with the possible excep- 
tion of spermatocytic seminoma [1]. 
CIS cells have a characteristic morphology ([5] for re- 
view) and their ploidy varies from peritriploid to penta- 
ploid [6-10]. Cytogenetic data of CIS are limited to only 
three cases, reported by us [11]. Karyotyping of CIS is trou- 
blesome, because tissue culturing has not been successful 
thus far, and direct harvesting is difficult because of the 
small number of tumor cells that can be obtained from the 
seminiferous tubules. Cytogenetics of CIS is important to 
understand the progression of CIS to invasive tumor and 
to shed light on the path ogenesis of TGCTs. 
In two cases, one seminoma (SE) and one nonsemi- 
nomatous TGCT (NS), we succeeded in karyotyping both 
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the invasive tumor and the CIS in the surrounding paren- 
chyma. 
CASE REPORTS 
Case I 
A 40-year-old patient presented with a mass in his right 
testis. Histologic examination of the orchiectomy speci- 
men showed a NS with the following components: embry- 
onal carcinoma, immature teratoma, mature teratoma, nd 
yolk sac tumor. The parenchyma adjacent o the tumor 
contained CIS. Remarkably, in one of the seminiferous tu- 
bules a trophoblastic giant cell was found in continuity 
with the CIS. 
Case II 
A 30-year-old patient presented with a mass in his right 
testis. Histologic examination of the orchiectomy speci- 
men showed a SE with scattered trophoblastic giant cells. 
The parenchyma was largely atrophic. Within the semini- 
ferous tubules there was extensive CIS. 
MATERIALS AND METHODS 
In both cases, after frozen section diagnosis material from 
the tumor and the parenchyma was separately processed 
for karyotyping. 
Short-term culturing and harvesting of the invasive NS 
and direct harvesting of the invasive SE were performed as 
described [12, 13]. To obtain CIS cells the method for di- 
rect harvesting of SE was also applied to the remaining pa- 
renchyma, surrounding the invasive tumor, which on light 
microscopy showed CIS. 
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F igure  1 Representative karyotypes of the CIS (a) and invasive NS (b) of Case I with the following karyotype 
descriptions, a) CIS, 69,XX, -Y , -5 , -6 ,+7,+8, -10, -11,+i (12) (p10)×2, -14, -18, -20,+21,+22,+22,+mar;  b) NS, 66, 
XXY,- 5 , -  6 , -  10, -  11,+i(12)(p10) ×2, -13 , -18 ,+21.  
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F igure  2 One of the two karyotypes of the CIS (a) and a representative karyotype of the invasive SE (b) of Case II with 
the fol lowing ka3:yotype descriptions, a) CIS, 68 ,XY , -X , -1 , -2 ,  add(2) (q? ) , -3 ,add(3) (q27) , -5 , -5 , -6 , -8 , -8 , -9 , -10 ,  
add(11)(q14), +?i(12)(p10). , -13  , -14  , -14  , -15  , i(15)[q10) , add(16}(q13) , -17  , -18  , -18  , +19 ,+add(19)(q13),+add(19) (q13), 
-20 , -22 ,+mar l  +14mar; b) SE, 73,XX¥,+add(1)(p13), -4 -5,+add(7)(q31) '+8'der(9)t(9;11)(p13;p11) ' -11, -11,+12,  
+i(12)(p10)× 2,~.13,+ del(14)(ql lq13),i(15 ) (q l0 ) , -  16,add(16)(q13),-  18,+ 19 , -  20,+ 21,+ 22,+2mar'  
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Table 1 Modal composite karyotypes of CIS and their invasive TGCTs 
Modal composite karyotype 
Case Carcinoma in situ Invasive tumor 
67-69,XXY,-5, -6,+8,-10, -  ll +i(12)(p10)x2, 
-18,-20,+21,+22[cp3] 
Clonal structural abnormalities 
add(2)(q?) 
i(15)(q10) 
add(19(q13) 
marl 
61-91,XxY, +Y , -5 , -6 , -10 , -11 ,  +i(12)(p10)x2, 
- 13,- 18,+21,+22[cp10] 
62-73,XXY,+add(1)(p13),- , -4,-  5,+add(7) 
(q31),der(9)t(9;11)(p13;p11),- 1 11,+ 12, 
+i(12)(p10)x2,- 13,i(15)(q10),- 16,add(16) 
(q13),- 17,- 18,+ 19,+ 21, + 2-6mar[cp6] 
Chromosomes were GPG banded (G-banding using Pan- 
creatin [Sigma, P3292, 0.1% in Hanks' solution] and Gi- 
emsa). A modal composite karyotype has been created 
according to ISCN 1991 [14]. However, the karyotypical de- 
scriptions are expressed in relation to the triploid level, to 
make specific over- and underrepresentation f chromo- 
somes, an important feature of the chromosomal pattern of 
TGCTs, better visible and comparable [15]. 
RESULTS 
From Case I three abnormal metaphases could be analyzed 
from the CIS component and 10 from the invasive tumor 
(NS). The representative karyotypes of the CIS and its in- 
vasive tumor, respectively are shown in Figures la and lb. 
From the CIS component of Case II two metaphases of 
substandard quality were found. From its invasive tumor 
(SE) six metaphases were analyzed. Figures 2a and 2b 
show, respectively, one of the two karyotypes of the CIS 
and a representative karyotype of the invasive tumor. 
Table 1 shows the modal composite karyotypes of CIS 
of Case I and the invasive tumors of both cases. Because of 
the substandard quality of the metaphases of the CIS of 
Case lI no modal composite karyotype is presented. Only 
the clonal structural abnormalities in the two metaphases 
are noted. 
Both cases of CIS revealed a peritriploid chromosome 
pattern: Case I (n = 68) and case II (n ~ 65; it was impossi- 
ble to determine the exact chromosome number of the CIS 
component of Case II). The karyotypes of CIS and the inva- 
sive tumor of Case I show an identical modal number of 
copies of the chromosomes X, 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 
12, 14, 15, 16, 17, 18, 19, 21, and 22. Moreover, they have 
an i(12p) as common structural abnormality. In Case II an 
i(15q) is present both in the CIS component and its inva- 
sive SE. An i(12p) chromosome, present in the invasive 
SE, might be present in one of the metaphases of the CIS 
(Fig. 2a) 
DISCUSSION 
Carcinogenesis of TGCTs starts early in life, probably in 
utero [1, 16]. Based on immunohistochemical and ultra- 
structural studies, CIS, derived from premalignant gono- 
cytes [17-19], is supposed to be the precursor of all TGCTs 
of adolescents and adults except spermatocytic seminoma 
[1]. Cytogenetic investigations of CIS may support this 
view and are important o shed light on the pathogenesis 
of TGCTs and to understand the progression of CIS to in- 
vasive tumor. 
In the two cases in which we succeeded in karyotyping 
both the invasive tumor and its adjacent CIS, we observed 
karyotypical similarities. In Case I, in CIS and its invasive 
NS, an identical number of modal copies of the chromo- 
somes X, 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 14, 15, 16, 17, 18, 
19, 21, and 22, and i(12p) was found. Despite the substan- 
dard quality of the two metaphases of CIS in Case II, we 
found an i(15q) both in the CIS and SE. An i(12p) chromo- 
some might also be present in both components. The kary- 
otypical similarities between CIS and the invasive tumor 
in both cases demonstrate their clonal relationship and 
strongly suggest hat we karyotyped the CIS that preceded 
the invasive cancer. As the testicular parenchyma adjacent 
to the tumor was free of invasive cancer, the abnormal 
metaphases harvested from the parenchyma must be de- 
rived from the CIS which was present in the seminiferous 
tubules. In our previous cytogenetic omparison of CIS 
with their invasive tumors (all NS) [11], no clear similarity 
was observed, except for two copies of i(12p) in both com- 
ponents in one case. It is conceivable that in these cases 
we failed to karyotype the CIS that was clonally related to 
the invasive tumor. CIS of the testis in general is very ex- 
tensive [4] and sometimes heterogeneous [20]. 
In the present study the karyotypes of the two cases of 
CIS revealed aperitriploid chromosome pattern. This find- 
ing is in keeping with our previous cytogenetic studies 
[11], as well as with ploidy studies [6-9]. Polyploidization 
of a dysplastic germ cell precursor resulting in CIS is sup- 
posed to be an early event in the carcinogenesis of TGCTs 
([21] for review). Noteworthy is the finding of an i(12p) in 
the CIS component of the three i(12p) positive invasive tu- 
mors (both cases in this study and Case 3 in our previous 
study [11]). This confirms that i(12p) formation is an early 
event in the oncogenesis of TGCTs (for review [15, 22]), al- 
though most likely preceded by polyploidization [23]. 
In conclusion, our results present for the first time cyto- 
genetic evidence that CIS is clonally related to and is the 
precursor for invasive TGCTs. 
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